VIEMED HEALTHCARE INC (VMD)

CA92663R1055 - Common Stock

8.22  +0.04 (+0.49%)

After market: 8.22 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
117.1M
-10.81%		138.8M
18.53%		183.008M
31.85%		219.27M
19.81%
EBITDA
YoY % growth
23.31M
-31.60%		24.23M
3.95%		36.837M
52.03%		53.783M
46.00%
EBIT
YoY % growth
12M
-51.02%		8.6M
-28.33%		14.975M
74.13%		22.119M
47.71%		N/A
Operating Margin
10.25%6.20%8.18%10.09%N/A
EPS
YoY % growth
0.22
-71.79%		0.15
-31.82%		0.26
73.33%		0.36
39.85%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		0.08
34.67%
Revenue
Q2Q % growth		53.025M
22.43%
EBITDA
Q2Q % growth		12.423M
EBIT
Q2Q % growth		4.949M
63.87%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 0.04 0.07-0.03-43.42%
Q4 2023
Q2Q % growth		 0.09
50.00%		0.10-0.01-10.89%
Q3 2023
Q2Q % growth		 0.07
133.33%		0.09-0.02-18.46%
Q2 2023
Q2Q % growth		 0.06
200.00%		0.050.0118.81%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 50.739M
35.27%		50.5M239K0.47%
Q3 2023
Q2Q % growth		 49.4M
38.14%		49.995M-595K-1.19%
Q2 2023
Q2Q % growth		 43.31M
30.02%		41.966M1.344M3.20%
Q1 2023
Q2Q % growth		 39.56M
22.63%		39.188M372K0.95%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -12.5% -12.2% -11.11%
Revenue0% -3.66% -1.32% -1.3%